Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-24

Clinical Trial Update: Ultrasound Guided Intra-sacroiliac Joint Injection: Methylprednisolone Versus Triamcinolone [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ultrasound-guided intra-sacroiliac joint injections of methylprednisolone versus triamcinolone for sacroiliac joint arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)
  • Triamcinolone (triamcinolone)

Snippet

Sponsor: Mansoura University | Conditions: Sacroiliac Joint Arthritis | Phase 2 | Status: UNKNOWN